Low Malignant Potential Ovarian Tumors: Borderline Ovarian Tumors

  • Hugh R. K. Barber

Abstract

A Committee of the International Federation of Gynecology and Obstetrics (FIGO) proposed a classification of common epithelial ovarian tumors as well as the clinical staging of these tumors. The classification and clinical staging, adopted in 1971, were the result of approximately 10 years of work by the Committee. The clinical staging has been revised on two occasions, the last being in 1987. Until that time there were as many classifications as there were hospitals in the country and as many subdivisions of these classifications as there were physicians in practice. Until the profession and scientists started to talk this common language, chaos reigned. It was impossible prior to establishment of the FIGO classification to compare results between centers and almost impossible to structure protocols for workup, management, and follow-up of patients with these tumors.

Keywords

Endometriosis Noma Rounded Teratoma Papilloma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Agrofo JO, Blancha A, Gibbs ACC, Langley FA: Histological discrimination of malignancy in mucinous ovarian tumors. Histopathology 1: 431, 1977.CrossRefGoogle Scholar
  2. Annual Report on the Results of Treatment in Gynecological Cancer. 20th Vol. Int J Obstet Gynecol Pettersson F (ed) Elsevier, Stockholm, FIGO, 1986.Google Scholar
  3. Annual Report on the Results of Treatment in Gynecological Cancer. 21th Vol. Int J Obstet Gynecol Pettersson F (ed) Elsevier, Stockholm, FIGO, 1990.Google Scholar
  4. Barber HRK: Ovarian cancer Part I. CA 29: 341, 1979; Part II. CA 30: 2, 1980.PubMedGoogle Scholar
  5. Barber HRK, Sommers SC, Snyder R Kwon TH: Histologic and nuclear grading and stromal reaction as indices for prognosis in ovarian cancer. Am J Obstet Gynecol 121: 795, 1975.PubMedGoogle Scholar
  6. Barnhill DR, O’Connor D: Management of ovarian neoplasms of low malignant potential. Oncology 5 (1): 21, 1991.PubMedGoogle Scholar
  7. Bell DA, Weinstock MA, Scully RL: Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer 62: 2212, 1988.PubMedCrossRefGoogle Scholar
  8. Burrmeister RE, Heckner RE, Franklin RR: Endosalpingiosis of the peritoneum. Obstet Gynecol 34: 310, 1969.Google Scholar
  9. Colgan T, Norris H: Ovarian epithelial tumors of low malignant potential: a review. Int J Gynecol Pathol 1: 367, 1983.PubMedCrossRefGoogle Scholar
  10. Copeland LJ: Review of article on management of ovarian neoplasms of low malignant potential. Oncology 5 (4): 31, 1991.Google Scholar
  11. Decker DG, Melkasian GD Jr, Taylor WF: The prognostic importance of histologic grading in ovarian cancer. Natl Cancer Inst Monogr 42: 9, 1975.PubMedGoogle Scholar
  12. Fenoglio CM, Frenczi A, Richart RM: Mucinous tumors of the ovary: ultrastructural studies of mucinous cystadenomas with histogenetic considerations. Cancer 36: 1709, 1975.PubMedCrossRefGoogle Scholar
  13. Fox H: Advantage in the histopathology in ovarian tumors: ovarian cancer. Adv Biosci 26: 9, 1980.Google Scholar
  14. Fox H, Langley FA: Tumors of the Ovary. Heinemann, London, 1976.Google Scholar
  15. Fox H, Agrawall K, Langley FA: A clinical pathologic study of 92 cases of granulosa cell tumors of the ovary, with special references to the factors influencing prognosis. Cancer 35: 231, 1975.PubMedCrossRefGoogle Scholar
  16. Friedlander ML, Russell P, Taylor IW, et al: Flow cytometric analyses of cellular DNA content as an adjunct to the diagnosis of borderline malignancy. Pathology 16: 301, 1984.PubMedCrossRefGoogle Scholar
  17. Gershenson DM, Silva EG: Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 65: 578, 1990.PubMedCrossRefGoogle Scholar
  18. Gondoz B: Electron microscopic studies of papillary serous tumors of the ovary. Cancer 27: 1455, 1971.CrossRefGoogle Scholar
  19. Hart WR: Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol 8: 541, 1977.PubMedCrossRefGoogle Scholar
  20. Hart WR, Norris HJ: Borderline and malignant mucinous tumors of the ovary: histologic criteria and clinical behavior. Cancer 31: 1031, 1973.PubMedCrossRefGoogle Scholar
  21. Herman RJ, Norris HJ: Germ cell tumors of the ovary. Pathol Annu 13: 291, 1978.Google Scholar
  22. Julian CJ, Woodruff JD: The biologic behavior of low grade papillary serous carcinoma of the ovary. Obstet Gynecol 40: 860, 1972.PubMedGoogle Scholar
  23. Katzenstein AL, Azor MT, Morgan TE, et al: Proliferative serous tumors of the ovary: histologic features and prognosis. Am J Surg Pathol 2: 339, 1978.PubMedCrossRefGoogle Scholar
  24. Lim-Tan SK, Cajigas HE, Scully RE: Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 72: 775, 1988.PubMedGoogle Scholar
  25. Marchand A, Fenoglio CM, Pasqual R, et al: Carcinoembryonic antigens in human ovarian neoplasm. Cancer Res 5: 3807, 1975.Google Scholar
  26. Roth L, Dallenbach-Hellweg G, Czernobrisky B: Ovarian Brenner tumors. Cancer 56: 582, 1985.PubMedCrossRefGoogle Scholar
  27. Roth L, Langley F, Fox H, et al: Ovarian clear cell adenofibromatous tumors. Cancer 53: 1156, 1984.PubMedCrossRefGoogle Scholar
  28. Rubin SC: Review of article on management of ovarian neoplasms of low malignant potential. Oncology 5 (4): 26, 1991.Google Scholar
  29. Russell P: Borderline epithelial tumors of the ovary: a conceptual dilemma. Clin Obstet Gynecol 11: 259, 1984.Google Scholar
  30. Sampson JA: Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg 10: 1, 1925.Google Scholar
  31. Scully RE: Gonadoblastoma: a review of 74 cases. Cancer 25: 1340, 1970.PubMedCrossRefGoogle Scholar
  32. Scully RE: Recent progress in ovarian cancer. Hum Pathol 1: 73, 1970.PubMedCrossRefGoogle Scholar
  33. Scully RE: Ovarian tumors: a review. Am J Pathol 87: 686, 1977.PubMedGoogle Scholar
  34. Serov SF, Scully RE: Histologic Typing of Ovarian Tumors. World Health Organization, Geneva, 1973.Google Scholar
  35. Snyder R, Norris H, Tavassoli F: Endometrioid proliferative and low malignant potential tumors of the ovary. Am J Surg Pathol 12: 661, 1988.PubMedCrossRefGoogle Scholar
  36. Woodruff JD: The pathogenesis of ovarian neoplasia. Johns Hopkins Med J 144: 117, 1979.PubMedGoogle Scholar
  37. Wynen JA, Rosenshein MB: Surgery in ovarian cancer. Arch Surg 115: 863, 1980.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1993

Authors and Affiliations

  • Hugh R. K. Barber
    • 1
  1. 1.Department of Obstetrics and GynecologyLenox Hill HospitalNew YorkUSA

Personalised recommendations